Recital 18, Decision_act (EU) 1996/435

In forcesince 16 Jan 1996

Kimberly-Clark has production plants in three European countries: the UK (four plants), France (two plants) and Germany (one plant). All these plants are dedicated to tissue manufacture and converting. The KC plants at [. . .] (5) have TAD technology.